EUVIMEDEUVIMED entdecken
Crossref

Discovery of Highly Selective HDAC2 Inhibitors in Cells That Elevate Histone Acetylation In Vivo without Adverse Effects from Dual Inhibition of HDAC1 and 2

Naoyuki Suzuki iD, Hidekuni Yamakawa, Ken Yoshihara, Kazuki Niidome, Kosuke Anan, Kenji Takaya, Kensuke Kouki, Kazuki Fujimoto iD, Hiroko Ono, Takaya Izumi, Kazuhiro Unemura, Mana Ito und 4 weitere

Journal of Medicinal Chemistry · 26.03.2026 · 69 (6) · 6429-6439

DOI: 10.1021/acs.jmedchem.5c02022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 17.03.2026. Verfasst von Naoyuki Suzuki und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan. Hauptthemen laut MEDLINE: Histone Deacetylase 2, Histone Deacetylase 1, Histone Deacetylase Inhibitors, Histones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase 2Histone Deacetylase 1Histone Deacetylase InhibitorsHistonesDrug DiscoveryHumansAcetylationAnimalsStructure-Activity RelationshipMice

Substanzen

Histone Deacetylase 2Histone Deacetylase 1Histone Deacetylase InhibitorsHistonesHDAC2 protein, humanHDAC1 protein, human

Autor:innen und Institutionen

  • Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan.
  • Laboratory for Drug Discovery and Disease Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan.
  • Laboratory for Drug Discovery and Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan.

ORCID-Profile: Naoyuki Suzuki, Kazuki Fujimoto, Ken-Ichi Kusakabe

Zitieren

APA

Suzuki, N., Yamakawa, H., Yoshihara, K., Niidome, K., Anan, K., Takaya, K., Kouki, K., Fujimoto, K., Ono, H., Izumi, T., Unemura, K., Ito, M., Hatta, T., Kido, Y., Horiguchi, N., & Kusakabe, K. I. (2026). Discovery of Highly Selective HDAC2 Inhibitors in Cells That Elevate Histone Acetylation In Vivo without Adverse Effects from Dual Inhibition of HDAC1 and 2. Journal of Medicinal Chemistry, 69(6), 6429-6439. https://doi.org/10.1021/acs.jmedchem.5c02022

Vancouver

Suzuki N, Yamakawa H, Yoshihara K, Niidome K, Anan K, Takaya K, et al. Discovery of Highly Selective HDAC2 Inhibitors in Cells That Elevate Histone Acetylation In Vivo without Adverse Effects from Dual Inhibition of HDAC1 and 2. Journal of Medicinal Chemistry. 2026;69(6):6429-6439. doi:10.1021/acs.jmedchem.5c02022

BibTeX
@article{Suzuki2026,
  author = {Suzuki, Naoyuki and Yamakawa, Hidekuni and Yoshihara, Ken and Niidome, Kazuki and Anan, Kosuke and Takaya, Kenji and Kouki, Kensuke and Fujimoto, Kazuki and Ono, Hiroko and Izumi, Takaya and Unemura, Kazuhiro and Ito, Mana and Hatta, Takuya and Kido, Yasuto and Horiguchi, Naotaka and Kusakabe, Ken-Ichi},
  title = {Discovery of Highly Selective HDAC2 Inhibitors in Cells That Elevate Histone Acetylation In Vivo without Adverse Effects from Dual Inhibition of HDAC1 and 2},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {6},
  pages = {6429--6439},
  doi = {10.1021/acs.jmedchem.5c02022}
}
Kostenlos starten →